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INTRODUCTION
The issues of dialysis adequacy are of rising 
medical and economic importance (6). The necessity 
of estimating the individual dialysis dose of patients 
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on periodic hemodialysis (HD) presents with two 
aspects. First comes the wish to achieve maximal 
blood purification and thus a reduced morbidity and 
mortality rates. Second come the economic realities 
influencing on quality and duration of HD as this is 
an extraordinarily expensive therapy. Urea kinetic 
modelling and parameters of dialysis adequacy are 
widely used worldwide although often criticized 
nowadays (13,14). 
According to the recommendation of Bulgarian 
medical standard of ‘Dialysis treatment’, a urea 
reduction ratio (URR)>65% or Kt/V>1,2 for every HD 
procedure (three times weekly) should be achieved in 
85% of the patients after three months of HD. HD 
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effectiveness (URR and Kt/V) should be estimated 
every three to four months.
Determination of the dialysis dose is usually 
performed by using URR and single pool model of 
Kt/V. Urea rebound after HD is determined as a 
rapid reverse increase of blood urea concentration 
resulting from its liberation from cells, tissues and 
organs where it exists in higher concentrations (9). 
Urea increases between 15 min and one hour after 
HD completion with a maximal value at 30th min 
(Fig. 1).
The objectives of the present study are to 
determine the average urea rebound by examining 
the urea concentrations immediately after completion 
of hemodialysis (HD) and comparing these results 
to urea concentrations taken 30 min after the 
procedure (equilibrated values), to assess how the 
delivered dialysis dose changes when URR and Kt/V 
are calculated using each of these two values and to 
evaluate the significance of these differences and the 
reliability of the indicators in use.
MATERIAL AND METHODS
The study covered 30 end-stage renal failure 
(ESRF) patients, 16 males and 14 females on chronic 
HD at a mean age of 43,90±10,63 years and average 
duration of dialysis treatment of 6,90±3,75 years. 
The vascular access was AV fistula in 24 patients 
and a permanent vascular catheter in 6 ones. Qb was 
between 220 and 350 mLl/min. Dialysis apparatuses 
Fresenius, series 4008 and bicarbonate buffer were 
used. Qd was 500 mL/min. HD was performed 
three times weekly, with heparinization bolus in 
the beginning of the procedure and with a mean 
duration time of 10,42±1,25 hours. Disposable 
capillary dialyzers with polysulphonic membrane 
were applied. Dialysis dose was calculated by using 
an own software (10) and MEDIX software from 
Germany.
The examinations were performed monthly for 
three months in all the patients. Mean urea values 
were calculated from three weekly measurements 
immediately and 30 min after HD. Besides the mean 
urea rebound percentage was calculated. By means 
of urea kinetic modelling, a total of 90 estimations 
of the indicators of dialysis adequacy such as Kt/
Vsp prescr., Kt/Vsp deliv., Kt/Vdp and URR were 
performed in all the patients. Blood samples were 
taken according to NKF-KDOQI Clinical Practice 
Guidelines for Hemodialysis Adequacy (7,11).
RESULTS
Mean urea values in samples taken immediately 
and 30 min after HD showed statistically significant 
differences (p<0,05). Equilibrating urea concentration 
led to an average increase of 17,7% at the 30th min 
after HD (Table 1). The calculations by means of urea 
kinetic modelling of MEDIX software and of our 
own software showed that Kt/Vsp=1,22±0,02 and Kt/
Vsp=1,23±0,11. There was no statistically significant 
difference between both methods (р=0,329; n=30) 
Fig. 1. Urea rebound – patient D. K., double pool model 
(UKM software MEDISC – Germany).
Fig. 2. Difference between mean values of URR and 
URRequ (1:2, p<0,5, n=30)
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while a high positive correlation was proved (r=0,975; 
р<0,01; CI=95%, n=60). Concerning the equilibrated 
urea values 30 min after HD, the difference after the 
calculation of Kt/Veqv=1,17±0,18 was statistically 
significant (p<0,05) (Fig. 2). The similar relations 
were established concerning the mean URR 
values obtained by means of non-equilibrated and 
equilibrated post-dialysis urea (Fig. 3). There was a 
statistically significant difference (p<0,05) between 
the calculated single pool Kt/V (1,23±0,11) and 
equilibrated Kt/V (1,17±0,18).
DISCUSSION
Rendering an account of single body pools is of 
importance when defining urea concentration and 
kinetics. The presence of such pools in the organism 
reduces the effectiveness of the extraction of uremic 
toxins localized there and induces rebound during 
which urea reaches its maximal value about 30 min 
after HD completion.
Disadvantages of single pool model (Кt/Vsр) 
can be corrected through the double pool model or 
an equilibrated parameter of dialysis adequacy (Кt/
Vequ).
Real-time monitoring of urea concentration 
occupies a leading position in the quantitative 
determination of dialysis dose (1,2,5). The differences 
of the urea values of the blood and dialysis end of the 
monitor enable the easy calculation of the standard 
urea kinetic parameters (4).
Fig. 3. Difference between mean values of Kt/Vsp and  

















1 13,4 15,8 18
2 11,3 13,2 17
3 8,1 10 23
4 13,9 15,6 12
5 8,3 9,8 18
6 10 11,3 13
7 11 12,8 16
8 12 14,3 19
9 11 13,7 25
10 13,5 15 11
11 12,7 14,6 15
12 9,9 11,8 19
13 7,3 9,1 25
14 12,9 14,8 15
15 10,9 12,6 16
16 6,3 8 27
17 13,8 16,5 20
18 9 11,3 26
19 17 18,9 11
20 12,8 14,7 15
21 13,9 15,6 12
22 8,3 9,8 18
23 10 11,3 13
24 11 12,8 16
25 12 14,3 19
26 13,5 15,9 18
27 12,7 14,6 15
28 9,9 11,8 19
29 7,3 9,1 25
30 12,9 14,8 15
Mean ± SD 11,22 2,47 13,13 2,60 17,7±4,5
1 2
Table 1. Mean urea values from three examinations 
immediately and 30 min after HD and mean urea 
rebound percentage in 30 patients on chronic HD
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Estimmation of ultraviolet-absorbance, blood 
urea, dialysate urea and ionic dialysance is used as 
clearance variation sensitivity (1,12).
Recently, a lot of publications dealing with 
the significant aspects of urea rebound (8) and 
urea kinetic modeling occur in the world literature 
available (3). Further comprehensive research is 
needed to elucidate in more detail these controversial 
issues.
CONCLUSION
Calculation of URR and single pool model of 
Kt/V for assessment of dialysis adequacy in ESRF 
patients on chronic HD results in overestimation 
of the delivered dialysis dose. These values differ 
statistically significantly from those when accounting 
for urea rebound. URR and Kt/Vsp indicators do not 
possess the necessary reliability as means to evaluate 
the delivered dialysis dose.
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